Penumbra (PEN) Current Leases (2019 - 2026)
Penumbra's (PEN) quarterly Current Leases came in at $2.4 million in Q1 2026, down 80.93% year-on-year from $12.5 million in Q1 2025, and little changed on a QoQ basis from $2.4 million in Q4 2025.
Penumbra (PEN) Current Leases (2019 - 2026) Analysis & Trends
Penumbra (PEN) has 8 years of Current Leases data on file, last reported at $2.4 million in Q1 2026.
- On a quarterly basis, Current Leases fell 80.93% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 80.93% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 80.42% from the prior year.
- Current Leases for Q1 2026 stood at $2.4 million, roughly flat from $2.4 million in the prior quarter.
- Over the last five years, Current Leases for PEN reached as high as $12.5 million in Q1 2025 and fell as low as $1.8 million in Q2 2022.
- Historically, Current Leases has averaged $5.2 million across 5 years, with a median of $2.4 million in 2025.
- Across the five-year window, Current Leases surged 502.64% in 2022 and slumped 80.93% in 2026, its largest moves.
- Year by year, Current Leases stood at $1.9 million in 2022, then advanced by 16.2% to $2.2 million in 2023, then surged by 447.78% to $12.2 million in 2024, then slumped by 80.42% to $2.4 million in 2025, then declined by 0.29% to $2.4 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 12.51 Mn |
| Dec 31, 2024 | 12.22 Mn |
| Sep 30, 2024 | 2.42 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 2.28 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | 10.83 Mn |
| Jun 30, 2023 | 10.72 Mn |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | 1.92 Mn |
| Sep 30, 2022 | 9.42 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 8.66 Mn |
| Dec 31, 2021 | 8.27 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | 1.40 Mn |